Evidence map›Paper›PMID 36235011›Full record

ArticleMolecules (Basel, Switzerland)2022

Molecular and Structural Analysis of Specific Mutations from Saudi Isolates of SARS-CoV-2 RNA-Dependent RNA Polymerase and their Implications on Protein Structure and Drug-Protein Binding.

Mubarak A Alamri, Muhammad Tahir Ul Qamar, Alhumaidi B Alabbas, Safar M Alqahtani, Manal A Alossaimi, Sikandar Azam, Muhammad Harris Hashmi, Muhammad Shahid Riaz Rajoka

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. TargetingMolecules (Basel, Switzerland) · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Mubarak A AlamriDepartment of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.ORCID 0000-0003-0678-593X
Muhammad Tahir Ul QamarIntegrative Omics and Molecular Modeling Laboratory, Department of Bioinformatics and Biotechnology, Government College University Faisalabad, Faisalabad 38000, Pakistan.ORCID 0000-0003-4832-4250
Alhumaidi B AlabbasDepartment of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
Safar M AlqahtaniDepartment of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.ORCID 0000-0002-4140-7320
Manal A AlossaimiDepartment of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.ORCID 0000-0001-8911-8109
Sikandar AzamDepartment of Virology, Graduate School of Medicine, Tohoku University, Sendai 980-8577, Japan.
Muhammad Harris HashmiUniversity of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0002-7622-4006
Muhammad Shahid Riaz RajokaDepartment of Microbial Pathogenesis, University of Maryland, Baltimore, MD 21201, USA.ORCID 0000-0003-0137-4584
Prince Sattam Bin Abdulaziz University · SAGovernment College University, Faisalabad · PKTohoku University · JPUniversity of Alabama at Birmingham · USUniversity of Maryland, Baltimore · US

Funding

Prince Sattam Bin Abdulaziz University 2021/03/19145
6 · The paper itself

Abstract

The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has stressed the global health system to a significant level, which has not only resulted in high morbidity and mortality but also poses a threat for future pandemics. This situation warrants efforts to develop novel therapeutics to manage SARS-CoV-2 in specific and other emerging viruses in general. This study focuses on SARS-CoV2 RNA-dependent RNA polymerase (RdRp) mutations collected from Saudi Arabia and their impact on protein structure and function. The Saudi SARS-CoV-2 RdRp sequences were compared with the reference Wuhan, China RdRp using a variety of computational and biophysics-based approaches. The results revealed that three mutations-A97V, P323I and Y606C-may affect protein stability, and hence the relationship of protein structure to function. The apo wild RdRp is more dynamically stable with compact secondary structure elements compared to the mutants. Further, the wild type showed stable conformational dynamics and interaction network to remdesivir. The net binding energy of wild-type RdRp with remdesivir is -50.76 kcal/mol, which is more stable than the mutants. The findings of the current study might deliver useful information regarding therapeutic development against the mutant RdRp, which may further furnish our understanding of SARS-CoV-2 biology.

Indexed as

COVID-19COVID-19 Drug TreatmentSARS-CoV-2Antiviral AgentsHumansMolecular Docking SimulationMutationPandemicsProtein BindingRNA-Dependent RNA PolymeraseRNA, ViralSaudi ArabiaAntiviral AgentsRNA-Dependent RNA PolymeraseRNA, ViralCOVID-19molecular dynamics simulationmutationsRdRpSARS-CoV-2

Identifiers

PMID36235011
PMCPMC9573158
OpenAlexW4303856635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.